Atara Biotherapeutics Inc
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.06 | -11.65 | -5.27 | -1.73 | -0.53 | -2.29 | -2.59 | -0.59 | -0.72 | -0.45 | -0.22 | -0.22 | -1.46 | |
| 0.28 | 0.28 | 0.25 | 0.22 | 0.16 | 0.10 | 0.17 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| 2.62 | 2.30 | 1.49 | 1.03 | 0.86 | 0.55 | 0.39 | 0.23 | 0.09 | 0.12 | 0.05 | 0.03 | 0.26 | |
| 0.46 | -1.68 | -2.09 | -0.55 | 0.88 | -2.10 | -7.57 | -1.04 | -0.58 | -0.16 | -0.05 | 0.05 | -0.66 | |
| 0.07 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 16.55 | 2.30 | 2.62 | 1.17 | -2.23 | 0.32 | 1.59 | -0.41 | -0.18 | 0.66 | – | -0.44 | – | |
| – | 0.02 | 0.00 | – | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| – | – | – | – | -0.03 | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.05 | 0.35 | 4.29 | -0.05 | 4.79 | -0.03 | -0.02 | 1.24 | 0.08 | 0.00 | 0.21 | 0.32 | 0.59 | |
| 4.44 | -9.00 | 1.64 | -0.61 | 2.03 | -2.00 | -1.03 | 0.24 | -0.82 | 0.22 | -0.01 | -0.34 | -0.91 | |
| -12.13 | -11.66 | -5.29 | -1.74 | -0.53 | -2.30 | -2.59 | -0.59 | -0.72 | -0.45 | -0.22 | -0.22 | -1.46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.